Advanced search
Publication Cover
Clinical, Cosmetic and Investigational Dermatology Volume 16, 2023 - Issue
Submit an article Journal homepage
211
Views
2
CrossRef citations to date
0
Altmetric
CASE REPORT

Terbinafine Induced Acute Generalized Exanthematous Pustulosis Treated with Adalimumab: Recalcitrant to Systemic Corticosteroid Therapy

Lin Deng1 Department of Dermatology Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-9574-4632View further author information
ORCID Icon,
Beilei He2 Department of the Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of ChinaView further author information
,
Kamran Ali1 Department of Dermatology Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China;3 Department of Dermatology, International Education College of Zhejiang Chinese Medical University, Hangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-0304-6130View further author information
ORCID Icon &
Zhangyu Bu1 Department of Dermatology Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 9-15 | Received 02 Oct 2022, Accepted 16 Dec 2022, Published online: 04 Jan 2023

References

  • Creadore A, Desai S, Alloo A, et al. Clinical characteristics, disease course, and outcomes of patients with acute generalized exanthematous pustulosis in the US. JAMA Dermatol. 2022;158(2):176–183. doi:10.1001/jamadermatol.2021.5390
  • Oh DAQ, Yeo YW, Choo KJL, Pang SM, Oh CC, Lee HY. Acute generalized exanthematous pustulosis: epidemiology, clinical course, and treatment outcomes of patients treated in an Asian academic medical center. JAAD Int. 2021;3:1–6. doi:10.1016/j.jdin.2020.12.004
  • Safa I, Ines L, Noureddine L, et al. Acute localized exanthematous pustulosis: clinical features, pathophysiology, and therapy. Dermatol Ther. 2021;34(5):e15087. doi:10.1111/dth.15087
  • Ellis CR, Azmat CE. Adalimumab. In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2022.
  • Wu L, Ali K, Qiu Y, Li M, Da J. Dupilumab-induced acute generalized exanthematous pustulosis in a 17-year-old female Chinese patient with atopic dermatitis. Acta Derm Venereol. 2022;102:adv00743. doi:10.2340/actadv.v102.1079
  • Hadavand MA, Kaffenberger B, Cartron AM, Trinidad JCL. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis. J Am Acad Dermatol. 2020;87(3):632–639. doi:10.1016/j.jaad.2020.09.024
  • Isom J, Braswell DS, Siroy A, Auerbach J, Motaparthi K. Clinical and histopathologic features differentiating acute generalized exanthematous pustulosis and pustular psoriasis: a retrospective series. J Am Acad Dermatol. 2020;83(1):265–267. doi:10.1016/j.jaad.2020.03.015
  • Sussman M, Napodano A, Huang S, Are A, Hsu S, Motaparthi K. Pustular psoriasis and acute generalized exanthematous pustulosis. Medicina. 2021;57(10):1004. doi:10.3390/medicina57101004
  • Copaescu AM, Bouffard D, Masse MS. Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: case presentation and literature review. Allergy Asthma Clin Immunol. 2020;16:9. doi:10.1186/s13223-020-0407-5
  • Sidoroff A, Dunant A, Viboud C, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol. 2007;157(5):989–996. doi:10.1111/j.1365-2133.2007.08156.x
  • Rawat BPS, Jagannatha A, Liu F, Inferring YH. ADR causality by predicting the Naranjo score from clinical notes. AMIA Annu Symp Proc. 2020;2020:1041–1049.
  • Lee J, Endicott A, Shinkai K. Acute generalized exanthematous pustulosis. JAMA Dermatol. 2021;157(5):589. doi:10.1001/jamadermatol.2020.5187
  • Liu J, Ali K, Lou H, Wang L, Wu L. First-trimester impetigo herpetiformis leads to stillbirth: a case report. Dermatol Ther. 2022;12(5):1271–1279. doi:10.1007/s13555-022-00735-9
  • Islamoğlu ZGK, Karabağli P. A case of recalcitrant acute generalized exanthematous pustulosis with Sjogren’s syndrome: successfully treated with low-dose cyclosporine. Clin Case Rep. 2019;7(9):1721–1724. doi:10.1002/ccr3.2352
  • Calogiuri G, Brockow K, Nettis E, Macchia L, Foti C, Vacca A. Promising use of the new biologics in the management of drug-induced hypersensitivity reactions: preliminary approaches. Endocr Metab Immune Disord Drug Targets. 2020;20(9):1456–1469. doi:10.2174/1871530320666200515113736
  • Gencoglan G, Tosun M, Aktepe F. The molecular mechanism of etanercept, an anti-tumour necrosis factor-alpha receptor-fusion protein, in the treatment of acute generalized exanthematous pustulosis. J Dermatolog Treat. 2009;20(4):241–245. doi:10.1080/09546630802683843
  • Zhang S, Tang S, Li S, Pan Y, Ding Y. Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review. J Dermatolog Treat. 2020;31(1):66–73. doi:10.1080/09546634.2019.1577548

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.